BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19341427)

  • 1. Distinct roles of the mTOR components Rictor and Raptor in MO7e megakaryocytic cells.
    Fuhler GM; Tyl MR; Olthof SG; Lyndsay Drayer A; Blom N; Vellenga E
    Eur J Haematol; 2009 Sep; 83(3):235-45. PubMed ID: 19341427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR phosphorylated at S2448 binds to raptor and rictor.
    Rosner M; Siegel N; Valli A; Fuchs C; Hengstschläger M
    Amino Acids; 2010 Jan; 38(1):223-8. PubMed ID: 19145465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
    Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
    J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.
    Rosner M; Hengstschläger M
    Hum Mol Genet; 2008 Oct; 17(19):2934-48. PubMed ID: 18614546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes.
    Kudchodkar SB; Yu Y; Maguire TG; Alwine JC
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14182-7. PubMed ID: 16959881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and association of mTOR with its cofactors, raptor and rictor, in cumulus cells and oocytes during meiotic maturation in mice.
    Kogasaka Y; Hoshino Y; Hiradate Y; Tanemura K; Sato E
    Mol Reprod Dev; 2013 Apr; 80(4):334-48. PubMed ID: 23440873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raptor-rictor axis in TGFbeta-induced protein synthesis.
    Das F; Ghosh-Choudhury N; Mahimainathan L; Venkatesan B; Feliers D; Riley DJ; Kasinath BS; Choudhury GG
    Cell Signal; 2008 Feb; 20(2):409-23. PubMed ID: 18068336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the mTOR pathway regulators in human pituitary adenomas indicates the clinical course.
    Jia W; Sanders AJ; Jia G; Liu X; Lu R; Jiang WG
    Anticancer Res; 2013 Aug; 33(8):3123-31. PubMed ID: 23898069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian target of rapamycin is required for thrombopoietin-induced proliferation of megakaryocyte progenitors.
    Drayer AL; Olthof SG; Vellenga E
    Stem Cells; 2006 Jan; 24(1):105-14. PubMed ID: 16123382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.
    Sarbassov DD; Ali SM; Kim DH; Guertin DA; Latek RR; Erdjument-Bromage H; Tempst P; Sabatini DM
    Curr Biol; 2004 Jul; 14(14):1296-302. PubMed ID: 15268862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
    Das G; Shiras A; Shanmuganandam K; Shastry P
    Mol Carcinog; 2011 Jun; 50(6):412-23. PubMed ID: 21557327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer.
    Wazir U; Newbold RF; Jiang WG; Sharma AK; Mokbel K
    Oncol Rep; 2013 May; 29(5):1969-74. PubMed ID: 23503572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function.
    Barilli A; Visigalli R; Sala R; Gazzola GC; Parolari A; Tremoli E; Bonomini S; Simon A; Closs EI; Dall'Asta V; Bussolati O
    Cardiovasc Res; 2008 Jun; 78(3):563-71. PubMed ID: 18250144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible raptor and rictor knockout mouse embryonic fibroblasts.
    Cybulski N; Zinzalla V; Hall MN
    Methods Mol Biol; 2012; 821():267-78. PubMed ID: 22125071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
    Zhang X; Wang X; Xu T; Zhong S; Shen Z
    Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy.
    Risson V; Mazelin L; Roceri M; Sanchez H; Moncollin V; Corneloup C; Richard-Bulteau H; Vignaud A; Baas D; Defour A; Freyssenet D; Tanti JF; Le-Marchand-Brustel Y; Ferrier B; Conjard-Duplany A; Romanino K; Bauché S; Hantaï D; Mueller M; Kozma SC; Thomas G; Rüegg MA; Ferry A; Pende M; Bigard X; Koulmann N; Schaeffer L; Gangloff YG
    J Cell Biol; 2009 Dec; 187(6):859-74. PubMed ID: 20008564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of chronic rejection in rat model system involves modulation of the mTORC1 and mTORC2 pathways.
    Zhang L; You J; Sidhu J; Tejpal N; Ganachari M; Skelton TS; Kloc M; Li XC; Ghobrial RM
    Transplantation; 2013 Nov; 96(9):782-90. PubMed ID: 23985719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy-related genes Raptor, Rictor, and Beclin1 expression and relationship with multidrug resistance in colorectal carcinoma.
    Shuhua W; Chenbo S; Yangyang L; Xiangqian G; Shuang H; Tangyue L; Dong T
    Hum Pathol; 2015 Nov; 46(11):1752-9. PubMed ID: 26363527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation.
    Carrière A; Cargnello M; Julien LA; Gao H; Bonneil E; Thibault P; Roux PP
    Curr Biol; 2008 Sep; 18(17):1269-77. PubMed ID: 18722121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTor plays an important role in odontoblast differentiation.
    Kim JK; Baker J; Nor JE; Hill EE
    J Endod; 2011 Aug; 37(8):1081-5. PubMed ID: 21763898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.